Fig. 2 | Scientific Reports

Fig. 2

From: Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans

Fig. 2

Classification of FBC organoids by morphological-specific markers. Mainly two types of FBC organoids from patient-derived tissues. The representative 6 cases of FBC organoids were classified by morphological-specific markers, luminal markers (CK8, CLDN3), and basal markers (CK5, CK17). As a reference to their morphology, their H&E staining was shown. Scale bar: 100 μm (A). Each marker was quantified. *P < 0.05 (B).

Back to article page